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Abstract: The chromatographic behaviour of some ACE inhibitors and their active
metabolites was examined under conditions of reversed-phase thin-layer chroma-
tography on RP-18 silica using water–methanol, water–ethanol and water–acetone
as binary solvent systems. The relationship between the RM values and the concen-
tration of organic modifier in the mobile phases was linear. It was found that an in-
crease in the content of the organic modifier in the employed solvent systems led to a
decrease of the RM values, i.e., of the retention. Also, the more hydrophobic com-
pounds had a longer retention. Based on regression analysis of the plots, the
lipophilicity parameters RM
0 and c0 were calculated. The chromatographically ob-
tained lipophilicity parameters were correlated with the calculated log P values.
Keywords: ACE inhibitors, reversed-phase thin-layer chromatography, lipophili-
city.
INTRODUCTION
Angiotensin converting enzyme (ACE) inhibitors are known as the most suit-
able drugs for the prevention and treatment of hypertension and congestive heart
failure. These well tolerated drugs are esterified pro-drugs which undergo enzymatic
in vivo hydrolysis to be converted into pharmacologically active metabolites, i.e., the
corresponding di-acid forms characterized by a high affinity for the ACE in arterial,
cardiac and renal tissues and a long-lasting and potent ACE inhibitory effect.1
A number of methods, such as high performance liquid chromatography
(HPLC), capillary zone electrophoresis and gas chromatography have been devel-
oped so far for the analysis of ACE inhibitors in biological fluids (urine or serum),
as well as in pharmaceutical formulations.2–5 However, only in a few papers were
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planar chromatography investigations of the above mentioned drugs described.6,7
There are no data in the available literature referring to systematic examinations of
the chromatographic behaviour and separation of a great number of ACE inhibitors
and their active metabolites.
In our previous studies of ACE inhibitors in different chromatographic sys-
tems,8–10 salting-out thin-layer chromatography (SOTLC) was found to be a suit-
able reversed-phase method for the investigation of their hydrophobicity. In con-
tinuation of these examinations, in the present work conventional reversed-phase
thin-layer chromatography (RP-TLC) was used for the separation and rapid hydro-
phobicity determination of several ACE inhibitors and their active metabolites.
EXPERIMENTAL
The substances investigated are listed in Table I.
The TLC experiments were performed on commercially available RP-18 silica (Art. 5559, E.
Merck, Darmstadt, Germany). The plates were spotted with 1.0 mL aliquots of freshly prepared
ethanolic solutions of enalapril, quinapril, fosinopril and cilazapril, aqueous solution of lisinopril
and methanolic solutions of enalaprilat, quinaprilat, fosinoprilat and cilazaprilat (about 2 mg/mL),
and were developed by the ascending technique.
Water–organic modifier binary systems of widely variable composition were used as the mo-
bile phase: A. water –methanol (40 – 80 vol %); B. water – ethanol (30 – 70 vol%) and C. water – ac-
etone (10 – 50 vol%).
All components of the employed mobile phases were of analytical grade purity.
After development, detection was performed by exposing the plates to iodine vapour. All in-
vestigations were performed at room temperature (22 ± 2 °C).
RESULTS AND DISCUSSION
The results obtained are listed in Table II. From these data it can be seen that an
increase in the concentration of the organic modifier in the mobile phase led to an in-
crease of the hRF values, i.e., to a decrease of the retention of the investigated sub-
stances. More hydrophobic compounds had a stronger retention compared to those
with hydrophilic groups in the molecule. Accordingly, the adsorption of the di-acid
forms of the ACE inhibitors (metabolites) was lower in comparison with the corre-
sponding pro-drug forms. For the same water content in the mobile phase, the reten-
tion was the strongest when methanol was used as the organic modifier. Simulta-
neously, in that case, the best selectivity in the separation of the metabolites originat-
ing from the corresponding pro-drugs was observed (the highest DRF values).
Disregarding the structural differences in the metabolites analyzed, a unique
retention order of these compounds was established when solvent systems A and B
were employed: RF(6) < RF(7) < RF(4) < RF(9) < RF(2). In the case when the mo-
bile phase C was used, an inversion in the order of compounds 7 and 4 was noticed,
although the differences in their RF values were relatively small. In contrast to the
metabolites, the pro-drug forms of the examined substances had a regular chro-
matographic behaviour, i.e., a unique order of the RF-values in all the examined
cases: RF(5) < RF(3) < RF(8) < RF(1).
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The chromatogrphic behaviour of the examined substances could be ex-
pressed by the RM values, which were calculated for each solute in each mobile
phase according to the Bate–Smith and Westall equation:11 RM = log (1/RF–1). In
all instances, a linear relationship between the RM values and the concentration of
organic modifier in mobile phases was established. This relationship can be ex-
pressed by the equation: RM = RM
0 + mc, where RM
0 represents the y-axis inter-
cept, m is the slope of the plot and c the concentration of the organic modifier.
From the obtained intercepts (RM
0) and the slopes (m), the hydrophobicity pa-
rameter c0 was calculated as c0 = –RM
0/m.12 The corresponding regression data are
listed in Table III. Both chromatographic parameters, RM
0 and c0, are generally
used for the characterization of hydrophobicity of molecules.13,14
From the results listed in Table III, it can be seen that, in most cases, the
hydrophobicity parameters RM
0 decreased when water–methanol as the mobile
phase was replaced by the water–acetone system. A lower lipophilicity of the
di-acid forms (metabolites) in comparison with those of the corresponding pro-dr-
ugs of the ACE inhibitors was clearly observed from the obtained RM
0 values.
Also, a significant difference in the hydrophobicity between the investigated ACE
624 ODOVI] et al.
Fig. 1. Correlation between the
hydrophobicity parameters RM
0
and c0 of the investigated sub-
stances and the calculated log
P values for different mobile
phases: water–methanol (A),
water–ethanol (B) and wat-
er–acetone (C). The numbers
on the lines denote the sub-
stances from Table I.
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inhibitors and their metabolites was confirmed by the values of the slopes (m),
which are related to the specific hydrophobic surface area of the solutes.15 Since
there are no data in the literature for experimentally determined log P values of the
investigated ACE inhibitors, the chromatographically determined hydrophobicity
parameters RM
0 and c0, were correlated with the calculated log P values
16 (Table
III) and the results are depicted in Fig. 1.
On the basis of these results, it can be seen that in both cases a satisfactory cor-
relation was obtained. However an even better correlation was observed for the
RM
0 parameters, especially for the solvent system methanol–water.
The results obtained by studying the pro-drug forms of the ACE inhibitors
demonstrate a perfect accordance of all the chromatographically determined hy-
drophobicity parameters (RM
0, m and c0), as well as of the calculated log P values
with the established retention order of these compounds.
CONCLUSIONS
The results presented in this paper indicate that reversed-phase thin-layer
chromatography is a suitable method for the separation of ACE inhibitors from
their metabolites. The separation of the investigated drugs is based on their
structural characteristics and their interaction with both the sorbent and the sol-
vents. Although the separation was satisfactory with all solvent systems employed,
the best results were obtained with acetone as the organic modifier. The satisfac-
tory correlations of RM
0, as a measure of hydrophobicity, with the values of the
slope (m) of the retention – concentration of organic modifier plots, as well as with
the calculated log P values indicate that reversed-phase thin-layer chromatography
represents a reliable method for the rapid, simple and inexpensive determination of
the hydrophobicity of the investigated compounds.
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REVERSNO-FAZNA TANKOSLOJNA HROMATOGRAFIJA NEKIH
INHIBITORA ANGIOTENZIN-KONVERTUJU]IH ENZIMA (ACE) I
WIHOVIH AKTIVNIH METABOLITA
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Ispitivano je hromatografsko pona{awe nekih ACE inhibitora i wihovih akti-
vnih metabolita u uslovima reversno-fazne tankoslojne hromatografije na RP-18
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silika-gelu primenom slede}ih binarnih sistema rastvara~a: voda–metanol, voda–eta-
nol i voda–aceton. Utvr|ena je linearna zavisnost izme|u RM–vrednosti i koncentra-
cije organskog modifikatora u mobilnoj fazi. Na|eno je da pove}awe sadr`aja organ-
skog modifikatora u upotrebqenom rastvara~u dovodi do opadawa RM-vrednosti,
odnosno do slabqewa retencije. Ja~a retencija uo~ena je za hidrofobnije supstance.
Na osnovu odgovaraju}ih regresionih podataka, izra~unati su parametri lipofilno-
sti RM
0 i c0. Hromatografski utvr|eni parametri lipofilnosti korelisani su sa
izra~unatim log P vrednostima.
(Primqeno 4. jula, revidirano 2. novembra 2005)
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